INTS9 anticorps (C-Term)
Aperçu rapide pour INTS9 anticorps (C-Term) (ABIN1881462)
Antigène
Voir toutes INTS9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 489-515, C-Term
-
Homologie
- B, Pr, M
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This INTS9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 489-515 amino acids from the C-terminal region of human INTS9.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000. WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
- INTS9 (Integrator Complex Subunit 9 (INTS9))
-
Autre désignation
- INTS9
-
Sujet
- Component of the Integrator complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes.
-
Poids moléculaire
- 73814
-
NCBI Accession
- NP_001138631, NP_001166033, NP_060720
-
UniProt
- Q9NV88
Antigène
-